Scientific team structures behind FDA-approved drugs
Yang, Alex J., Freeman, Richard B., Deng, Sanhong
Springer Nature ·
2026-11-01
· DOI 10.1038/s41587-026-03366-z
Abstract
A comprehensive analysis of the patents and papers behind drugs approved by the US Food and Drug Administration (FDA) reveals that successful therapeutic innovation relies on large, experienced and geographically diverse teams concentrated in a handful of elite institutions.
Yang, Alex J., Freeman, Richard B., Deng, Sanhong. Scientific team structures behind FDA-approved drugs. // Nature Biotechnology. – 2026. – DOI: 10.1038/s41587-026-03366-z. – URL: https://www.nature.com/articles/s41587-026-03366-z
Yang, Alex J, Freeman, Richard B, Deng, & Sanhong (2026). Scientific team structures behind FDA-approved drugs. Nature Biotechnology. https://doi.org/10.1038/s41587-026-03366-z
Yang, et al. “Scientific team structures behind FDA-approved drugs.” Nature Biotechnology, 2026. doi:10.1038/s41587-026-03366-z.
@article{Yang2026,
title = {Scientific team structures behind FDA-approved drugs},
author = {Yang and J., Alex and Freeman and B., Richard and Deng and Sanhong},
journal = {Nature Biotechnology},
year = {2026},
doi = {10.1038/s41587-026-03366-z},
url = {https://www.nature.com/articles/s41587-026-03366-z}
}